A 28-year-old man with known HIV infection presents with perianal discomfort and a sensation of incomplete evacuation. Physical exam reveals multiple well-defined, verrucous lesions around the anus. Biopsy with HPV typing confirms infection with HPV type 16. What is the most appropriate next step in management?
সমাধান
সঠিক উত্তর: Option B
- In this case, a 28-year-old HIV-positive man presents with perianal verrucous lesions confirmed to be caused by high-risk HPV type 16, which is strongly associated with anal intraepithelial neoplasia (AIN) and anal cancer.
- Given the presence of these lesions and the patient's immunocompromised status, the primary concern is to evaluate for high-grade dysplasia or early anal cancer.
Key Points:
- HPV type 16 is a high-risk oncogenic strain linked to anal squamous cell carcinoma.
- Patients with HIV infection are at increased risk for HPV-associated anal dysplasia and malignancy due to immunosuppression.
- The presence of verrucous lesions and symptoms such as a sensation of incomplete evacuation suggest possible underlying high-grade anal intraepithelial lesions or early cancer.
- Topical treatments like podophyllin (Option 1) are effective for low-grade external warts but do not address underlying dysplasia or cancer risk.
- Oral acyclovir (Option 3) is used for herpes simplex virus infection, which is unrelated to HPV lesions.
- Wide local excision (Option 4) without proper staging and evaluation risks incomplete treatment and morbidity, as lesions may be multifocal.
Most Appropriate Next Step:
- High-resolution anoscopy (HRA) with targeted biopsy allows detailed visualization of the anal canal mucosa, identification of suspicious lesions, and biopsy to diagnose histological grade of dysplasia.
- This approach guides further management, including close surveillance, topical therapies, ablative treatments, or surgery depending on biopsy results.
- It is considered the standard of care for screening and diagnosis of anal neoplasia in high-risk patients, especially those with HIV and HPV 16 infection.
Reference: Harrison's Principles of Internal Medicine, 20th Edition, Volume 2, Chapter 288: Human Papillomavirus and Anal Neoplasia
- Given the presence of these lesions and the patient's immunocompromised status, the primary concern is to evaluate for high-grade dysplasia or early anal cancer.
Key Points:
- HPV type 16 is a high-risk oncogenic strain linked to anal squamous cell carcinoma.
- Patients with HIV infection are at increased risk for HPV-associated anal dysplasia and malignancy due to immunosuppression.
- The presence of verrucous lesions and symptoms such as a sensation of incomplete evacuation suggest possible underlying high-grade anal intraepithelial lesions or early cancer.
- Topical treatments like podophyllin (Option 1) are effective for low-grade external warts but do not address underlying dysplasia or cancer risk.
- Oral acyclovir (Option 3) is used for herpes simplex virus infection, which is unrelated to HPV lesions.
- Wide local excision (Option 4) without proper staging and evaluation risks incomplete treatment and morbidity, as lesions may be multifocal.
Most Appropriate Next Step:
- High-resolution anoscopy (HRA) with targeted biopsy allows detailed visualization of the anal canal mucosa, identification of suspicious lesions, and biopsy to diagnose histological grade of dysplasia.
- This approach guides further management, including close surveillance, topical therapies, ablative treatments, or surgery depending on biopsy results.
- It is considered the standard of care for screening and diagnosis of anal neoplasia in high-risk patients, especially those with HIV and HPV 16 infection.
Reference: Harrison's Principles of Internal Medicine, 20th Edition, Volume 2, Chapter 288: Human Papillomavirus and Anal Neoplasia